At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRCT PROCEPT BioRobotics
Trading 03-27 12:52:56 EDT
25.06
-0.01
-0.04%
High25.29Low24.10Vol309.56K
Open24.91D1 Closing25.07Amplitude4.75%
Mkt Cap1.41BTradable Cap1.34BTotal Shares56.39M
T/O7.67MT/O Rate0.58%Tradable Shares53.56M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

How Investors May Respond To PROCEPT BioRobotics (PRCT) Winning Strong EAU Backing For Aquablation
Simply Wall St.  ·  03-26 14:06
How Investors May Respond To PROCEPT BioRobotics (PRCT) Winning Strong EAU Backing For Aquablation
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT)
TIPRANKS  ·  03-22
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT)
Top Executive Quietly Unloads PROCEPT BioRobotics Shares in Notable Insider Move
TIPRANKS  ·  03-20
Top Executive Quietly Unloads PROCEPT BioRobotics Shares in Notable Insider Move
Procept BioRobotics EVP, CLO and Corporate Secretary Nouri Alaleh disposes of USD 138,000 in common shares
Reuters  ·  03-20
Procept BioRobotics EVP, CLO and Corporate Secretary Nouri Alaleh disposes of USD 138,000 in common shares
Levi & Korsinsky Investigates Procept BioRobotics After USD 17.4 Million Revenue Shortfall
Reuters  ·  03-19
Levi & Korsinsky Investigates Procept BioRobotics After USD 17.4 Million Revenue Shortfall
Why PROCEPT BioRobotics (PRCT) Is Up 10.8% After Expanding Its AI-Enabled HYDROS System Internationally
Simply Wall St.  ·  03-18
Why PROCEPT BioRobotics (PRCT) Is Up 10.8% After Expanding Its AI-Enabled HYDROS System Internationally
Levi & Korsinsky probes Procept BioRobotics over possible federal securities law violations
Reuters  ·  03-16
Levi & Korsinsky probes Procept BioRobotics over possible federal securities law violations
Procept Biorobotics® Announces International Launch of the Hydros® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
THOMSON REUTERS  ·  03-12
Procept Biorobotics® Announces International Launch of the Hydros® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
GlobeNewswire  ·  03-12
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)?
Simply Wall St.  ·  03-10
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)?
Baird Initiates PROCEPT BioRobotics at Neutral With $30 Price Target
MT Newswires Live  ·  03-06
Baird Initiates PROCEPT BioRobotics at Neutral With $30 Price Target
Procept BioRobotics names Daniel Puckett to board and audit committee
Reuters  ·  03-06
Procept BioRobotics names Daniel Puckett to board and audit committee
PROCEPT BioRobotics Initiated at Neutral by Baird
Dow Jones  ·  03-06
PROCEPT BioRobotics Initiated at Neutral by Baird
Procept BioRobotics initiated with a Neutral at Baird
TIPRANKS  ·  03-06
Procept BioRobotics initiated with a Neutral at Baird
Levi & Korsinsky Launches Fraud Probe Into Procept BioRobotics
Reuters  ·  03-04
Levi & Korsinsky Launches Fraud Probe Into Procept BioRobotics
Stock Track | PROCEPT BioRobotics Plunges 9.39% in After-Hours Trading Following Multiple Analyst Price Target Cuts
Stock Track  ·  03-03
Stock Track | PROCEPT BioRobotics Plunges 9.39% in After-Hours Trading Following Multiple Analyst Price Target Cuts
Procept BioRobotics price target lowered to $30 from $62 at UBS
TIPRANKS  ·  03-02
Procept BioRobotics price target lowered to $30 from $62 at UBS
PROCEPT BioRobotics Is Maintained at Buy by Truist Securities
Dow Jones  ·  03-02
PROCEPT BioRobotics Is Maintained at Buy by Truist Securities
Truist Adjusts Price Target on PROCEPT BioRobotics to $30 From $47, Maintains Buy Rating
MT Newswires Live  ·  03-02
Truist Adjusts Price Target on PROCEPT BioRobotics to $30 From $47, Maintains Buy Rating
PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial
TIPRANKS  ·  03-02
PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial

Introduction

Company Name.
PROCEPT BioRobotics
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Issue price:
--